Augmentation of EMDR with multifocal transcranial current stimulation (MtCS) in the treatment of fibromyalgia: study protocol of a double-blind randomized controlled exploratory and pragmatic trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
29 Jan 2021
Historique:
received: 11 05 2020
accepted: 12 01 2021
entrez: 30 1 2021
pubmed: 31 1 2021
medline: 9 2 2021
Statut: epublish

Résumé

Fibromyalgia (FM) is a generalized, widespread chronic pain disorder affecting 2.7% of the general population. In recent years, different studies have observed a strong association between FM and psychological trauma. Therefore, a trauma-focused psychotherapy, such as eye movement desensitization and reprocessing (EMDR), combined with a non-invasive brain stimulation technique, such as multifocal transcranial current stimulation (MtCS), could be an innovative adjunctive treatment option. This double-blind randomized controlled trial (RCT) analyzes if EMDR therapy is effective in the reduction of pain symptoms in FM patients and if its potential is boosted with the addition of MtCS. Forty-five patients with FM and a history of traumatic events will be randomly allocated to Waiting List, EMDR + active-MtCS, or EMDR + sham-MtCS. Therapists and patients will be kept blind to MtCS conditions, and raters will be kept blind to both EMDR and MtCS. All patients will be evaluated at baseline, post-treatment, and follow-up at 6 months after post-treatment. Evaluations will assess the following variables: sociodemographic data, pain, psychological trauma, sleep disturbance, anxiety and affective symptoms, and wellbeing. This study will provide evidence of whether EMDR therapy is effective in reducing pain symptoms in FM patients, and whether the effect of EMDR can be enhanced by MtCS. ClinicalTrials.gov NCT04084795 . Registered on 2 August 2019.

Sections du résumé

BACKGROUND BACKGROUND
Fibromyalgia (FM) is a generalized, widespread chronic pain disorder affecting 2.7% of the general population. In recent years, different studies have observed a strong association between FM and psychological trauma. Therefore, a trauma-focused psychotherapy, such as eye movement desensitization and reprocessing (EMDR), combined with a non-invasive brain stimulation technique, such as multifocal transcranial current stimulation (MtCS), could be an innovative adjunctive treatment option. This double-blind randomized controlled trial (RCT) analyzes if EMDR therapy is effective in the reduction of pain symptoms in FM patients and if its potential is boosted with the addition of MtCS.
METHODS METHODS
Forty-five patients with FM and a history of traumatic events will be randomly allocated to Waiting List, EMDR + active-MtCS, or EMDR + sham-MtCS. Therapists and patients will be kept blind to MtCS conditions, and raters will be kept blind to both EMDR and MtCS. All patients will be evaluated at baseline, post-treatment, and follow-up at 6 months after post-treatment. Evaluations will assess the following variables: sociodemographic data, pain, psychological trauma, sleep disturbance, anxiety and affective symptoms, and wellbeing.
DISCUSSION CONCLUSIONS
This study will provide evidence of whether EMDR therapy is effective in reducing pain symptoms in FM patients, and whether the effect of EMDR can be enhanced by MtCS.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT04084795 . Registered on 2 August 2019.

Identifiants

pubmed: 33514408
doi: 10.1186/s13063-021-05042-w
pii: 10.1186/s13063-021-05042-w
pmc: PMC7844777
doi:

Banques de données

ClinicalTrials.gov
['NCT04084795']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Références

Front Neurosci. 2016 Nov 30;10:550
pubmed: 27965533
Wiley Interdiscip Rev Cogn Sci. 2014 Nov;5(6):649-659
pubmed: 26308871
Neurosci Biobehav Rev. 2018 Sep;92:291-303
pubmed: 29763711
Occup Med (Lond). 2014 Jul;64(5):393-4
pubmed: 25005549
Cleve Clin J Med. 2018 May;85(5):367-376
pubmed: 29733785
J Nerv Ment Dis. 1995 Apr;183(4):231-5
pubmed: 7714511
Rev Esp Salud Publica. 2020 Jan 10;94:
pubmed: 31919340
Semin Arthritis Rheum. 2002 Aug;32(1):38-50
pubmed: 12219319
J Psychosom Res. 1967 Aug;11(2):213-8
pubmed: 6059863
Fortschr Neurol Psychiatr. 2017 Oct;85(10):584-591
pubmed: 29017196
J Rheumatol. 1991 May;18(5):728-33
pubmed: 1865419
J Neural Transm (Vienna). 2017 Jul;124(7):799-808
pubmed: 28321566
Curr Pain Headache Rep. 2013 Aug;17(8):356
pubmed: 23801009
J Rehabil Med. 2017 Jan 19;49(1):2-9
pubmed: 27983739
PLoS One. 2013 Aug 07;8(8):e69460
pubmed: 23950894
J Rheumatol. 2020 Apr;47(4):624-631
pubmed: 31371651
Brain Stimul. 2013 May;6(3):465-7
pubmed: 23031723
Brain Stimul. 2016 Sep-Oct;9(5):641-661
pubmed: 27372845
J Interpers Violence. 2013 May;28(7):1498-518
pubmed: 23266990
Arthritis Res Ther. 2011 Apr 28;13(2):211
pubmed: 21542893
Rev Lat Am Enfermagem. 2012 Jan-Feb;20(1):76-83
pubmed: 22481724
Turk J Phys Med Rehabil. 2018 Feb 25;64(2):91-99
pubmed: 31453497
Open Rheumatol J. 2011;5:45-50
pubmed: 22046206
Psychiatr Clin North Am. 2018 Sep;41(3):447-463
pubmed: 30098657
J Neurosci Res. 2017 Jun;95(6):1257-1270
pubmed: 27402412
Neuropsychologia. 2018 Aug;117:156-166
pubmed: 29727626
J Nerv Ment Dis. 2015 Jun;203(6):443-51
pubmed: 25974059
Int Clin Psychopharmacol. 2015 Jul;30(4):183-92
pubmed: 25932596
J Nerv Ment Dis. 1996 Nov;184(11):688-94
pubmed: 8955682
Pain. 1983 Sep;17(1):45-56
pubmed: 6226917
Front Hum Neurosci. 2016 Mar 10;10:68
pubmed: 27014012
Clin Psychol Rev. 2016 Feb;43:128-41
pubmed: 26574151
Cochrane Database Syst Rev. 2018 Apr 13;4:CD008208
pubmed: 29652088
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Int Rev Psychiatry. 2017 Apr;29(2):146-167
pubmed: 28523976
Nurs Clin North Am. 2018 Sep;53(3):349-360
pubmed: 30100001
Clin Neurophysiol. 2015 Jun;126(6):1071-1107
pubmed: 25797650
Front Psychol. 2017 Oct 10;8:1750
pubmed: 29066991
Curr Pain Headache Rep. 2009 Oct;13(5):350-7
pubmed: 19728960
J Psychosom Res. 2000 Jun;48(6):555-60
pubmed: 11033374
Clin Psychol Rev. 2009 Nov;29(7):599-606
pubmed: 19616353
J Consult Clin Psychol. 2001 Apr;69(2):305-16
pubmed: 11393607
Arthritis Rheum. 2006 Dec;54(12):3988-98
pubmed: 17133529
Psicothema. 2017 May;29(2):275-280
pubmed: 28438254
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:347-360
pubmed: 30312634
J Clin Psychol. 2002 Dec;58(12):1505-20
pubmed: 12455018
Semin Arthritis Rheum. 2018 Aug;48(1):121-133
pubmed: 29428291
J Pain Res. 2018 Sep 28;11:2107-2113
pubmed: 30319285
Pain Pract. 2007 Dec;7(4):297-306
pubmed: 17986164
Qual Life Res. 2011 Aug;20(6):931-7
pubmed: 21210225
Brain Sci. 2019 Apr 14;9(4):
pubmed: 31013983
Pain Res Treat. 2012;2012:585419
pubmed: 22135739
Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69):S73-8
pubmed: 22243552
Psychol Psychother. 2018 Mar;91(1):63-78
pubmed: 28834138
Sci Rep. 2017 Dec;7(1):135
pubmed: 28273933
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Jan-Feb;24(1):7-10
pubmed: 8900971
Neuron. 2010 Apr 29;66(2):198-204
pubmed: 20434997
Curr Opin Rheumatol. 2018 Jan;30(1):94-100
pubmed: 29040155
Brain Stimul. 2017 Sep - Oct;10(5):893-901
pubmed: 28684258
J Adv Nurs. 2016 Sep;72(9):2207-17
pubmed: 27134066
BMC Health Serv Res. 2014 Nov 11;14:513
pubmed: 25385047
Pain Physician. 2017 Mar;20(3):139-154
pubmed: 28339428
Am J Psychiatry. 1994 Aug;151(8):1132-6
pubmed: 8037246
PLoS One. 2014 Aug 07;9(8):e103676
pubmed: 25101684
Pain. 1990 Feb;40(2):171-182
pubmed: 2308763
Front Psychiatry. 2016 Dec 20;7:201
pubmed: 28066274
Psychol Med. 2006 Nov;36(11):1515-22
pubmed: 16740177
Curr Behav Neurosci Rep. 2016 Jun;3(2):95-101
pubmed: 29479515
Medsurg Nurs. 2012 Sep-Oct;21(5):321-2
pubmed: 23243796
Rev Neurol. 2017 Oct 16;65(8):353-360
pubmed: 28990645
J Pain Manag. 2009;2(3):353-361
pubmed: 21170277
Clin J Pain. 2018 May;34(5):421-427
pubmed: 28877142
Glob Health Action. 2017;10(1):1275191
pubmed: 28333581
Neuroimage. 2014 Apr 1;89:216-25
pubmed: 24345389
Pain. 2015 Jan;156(1):62-71
pubmed: 25599302
Psychol Res Behav Manag. 2019 Feb 13;12:117-127
pubmed: 30858740
Prim Care. 2018 Jun;45(2):325-341
pubmed: 29759127
Front Hum Neurosci. 2019 Feb 11;13:40
pubmed: 30804771

Auteurs

I Gardoki-Souto (I)

Centre Forum Research Unit, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, C/ Llull 410, 08019, Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

O Martín de la Torre (O)

Cognitive NeuroLab, Universitat Oberta de Catalunya (UOC), Barcelona, Spain.

B Hogg (B)

Centre Forum Research Unit, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, C/ Llull 410, 08019, Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

D Redolar-Ripoll (D)

Cognitive NeuroLab, Universitat Oberta de Catalunya (UOC), Barcelona, Spain.

A Valiente-Gómez (A)

Centre Forum Research Unit, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, C/ Llull 410, 08019, Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain.

L Martínez Sadurní (L)

Institut de Neuropsiquiatria i Addiccions (INAD), Parc de Salut Mar, Barcelona, Spain.

J M Blanch (JM)

Service of Rheumatology, Parc de Salut Mar, Barcelona, Spain.

W Lupo (W)

Centre Forum Research Unit, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, C/ Llull 410, 08019, Barcelona, Spain.

V Pérez (V)

Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain.

J Radua (J)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Karolinska Institutet, Solna, Sweden.
King's College, London, England.

B L Amann (BL)

Centre Forum Research Unit, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, C/ Llull 410, 08019, Barcelona, Spain.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Centro de Investigación Biomédica en Red Salud Mental (CIBERSAM), Madrid, Spain.

A Moreno-Alcázar (A)

Centre Forum Research Unit, Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, C/ Llull 410, 08019, Barcelona, Spain. amoreno.centreforum@gmail.com.
Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. amoreno.centreforum@gmail.com.
Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. amoreno.centreforum@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH